Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Slow-wave Sleep Enhancement in Those at Risk for Alzheimer's Disease: Links With Memory, Excitotoxicity, and Plasma A-beta

NCT05138848 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT05138848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05138848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Slow-wave Sleep Enhancement in Those at Risk for Alzheimer's Disease: Links With Memory, Excitotoxicity, and Plasma A-beta
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Completed
Start date
January 3, 2022
Completion date
June 30, 2026
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, late onset, amyloid, cognitive change, mild cognitive impairment, sleep